Together with other immune cell populations, ILCs participate in IBD pathogenesis through interaction with the microbiota, modulation of epithelial barrier integrity, and the production of cytokines such as IL-22 and IL-17 [43,45,47,57,118,173,174] (Figure 5). The gene discussed is IL17A; the disease is inflammatory bowel disease.